iShs Biotechnology (IBB)

With the Federal Reserve's "hike or no hike" decision ending anti-climatically last week, Wall Street turns its attention to the rising odds of another government shutdown.

How to Play the Market’s Worst Month for U.S. Stocks With ETFs

By Todd Shriber, InvestorPlace Contributor Sep 8, 2015

August was a brutal month for stocks, but now the door is open for bargain hunting with ETFs.

IBB: This Biotech ETF Still Looks Short-Worthy

By Serge Berger, InvestorPlace Contributor Sep 1, 2015

The market's turbulence really did a number on darlings like the biotech ETF, IBB. Traders should look to get short on the IBB.

The Best Way to Buy Biotech Stocks: A Heated Debate

By Todd Shriber, InvestorPlace Contributor Aug 28, 2015

Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers.

CELG Stock: Embrace the Biotech Boom With Celgene Calls

By Tyler Craig, Tales of a Technician Aug 18, 2015

Celgene (CELG) stock is offering an attractive buying opportunity. Snatch up long CELG calls on the cheap to profit.

Soft Economic Data Can’t Hold Wall Street Back

By Anthony Mirhaydari, InvestorPlace Market Strategist Aug 17, 2015

Stocks won out on a low-volume Monday, though large caps returned to the middle of their sideways trading range.

Market Holds Big-Picture Support, but Will It Last?

By Serge Berger, InvestorPlace Contributor Aug 10, 2015

The longer-term charts show the trend is still up.

Disney Dunks the Dow to Six-Month Lows

By Anthony Mirhaydari, InvestorPlace Market Strategist Aug 6, 2015

Wall Street is a graveyard for highfliers of late, with Disney (DIS), Tesla (TSLA) and Apple (AAPL) helping to pull the broader indices lower.

Nasdaq Sets New Highs as Greece Nears Exit

By Anthony Mirhaydari, InvestorPlace Market Strategist Jun 18, 2015

The Nasdaq reset its high-water mark on Thursday as post-Fed buying took hold. Now the onus is on the bulls to show they're going to follow through.

BioMarin (BMRN) Stock Soars, Taking IBB With It

By John Divine, InvestorPlace Assistant Editor Jun 18, 2015

BioMarin (BMRN) stock is soaring on Thursday after promising Phase 2 trial data on a dwarfism drug, vosoritide. The IBB ETF is rallying, too.

Trade of the Day: IBB is Your Best Bet in Biotech

By Sam Collins, InvestorPlace Chief Technical Analyst Jun 15, 2015

iShares NASDAQ Biotechnology Index (ETF) looks ready to break out.

IBB: Are Biotech Stocks Readying a Final Summertime Hurrah?

By Serge Berger, InvestorPlace Contributor Jun 9, 2015

Biotech stocks have had an unprecedented run in recent years, and while a mean-reversion move is in the cards, traders can still ride the IBB ETF higher.

Can Biotech Stocks Break Out, Or Will They Break Down?

By Jon Markman, Editor, Trader's Advantage and CounterPoint Options Jun 1, 2015

Biotech stocks are a step up from lottery tickets: Fortunes made and lost on the clinical results and regulatory approval. Will they break down or break out?